i-Tail paid $160 million for Illinois treat maker Phelps Pet Products

The Thai manufacturer now owns the Illinois and Wisconsin plants that make treats for brands it competes against on shelf.

i-Tail paid $160 million for Illinois treat maker Phelps Pet Products

Photo: No Revisions · Unsplash

A brand that contracts with Phelps Pet Products to make its treats just learned that its co-manufacturer is now owned by a company whose own treat lines sit three feet away on the same shelf.

i-Tail Corporation, the Thai pet food manufacturer and subsidiary of seafood giant Thai Union Group, acquired Phelps for an enterprise value of $160 million. Phelps operates manufacturing facilities in Illinois and Wisconsin and makes clean-label, protein-first treats and specialty nutrition products for retailers and pet food brands across North America. In 2025, Phelps generated $70.3 million in net sales and posted a compound annual growth rate of 25.6% between 2023 and 2025.

The decision brands using Phelps face now

If a brand contracts with Phelps to produce its treats, its formulation, its customer list, and its production schedule are now visible to a vertically integrated competitor. i-Tail's own treat segment grew 62.3% year over year in the second quarter of fiscal 2026, reaching 925 million baht (about $29 million), and the company rolled out more than 400 new SKUs in the first six months of the year. In the first half of fiscal 2026, treats represented 20% of i-Tail's total pet food revenue, up from a range of 10% to 21% in the 2023 to 2025 period.

According to i-Tail, the transaction broadens its treat and specialty nutrition footprint by pairing Phelps' capabilities in dog nutrition, air-dried formats, and jerky-style products with i-Tail's existing wet cat food operations. Roy Chan, i-Tail's CEO, called the deal "an important milestone in our growth journey, supporting our aspirational target of reaching up to $1.5 billion in annual revenue by 2030."

Rick Ruffolo, Phelps' CEO and president, said the combined entity can "broaden our collective product offerings through cross-selling and exploring opportunities in new categories, which will enable our respective customers to innovate and grow market share." That cross-selling runs both directions: i-Tail gains US manufacturing capacity in its largest market, and Phelps' contract customers now share production lines with a competitor.

What to do if Phelps makes your line

Pull your contract and read the exclusivity and confidentiality clauses. Most co-manufacturing agreements include non-compete language that prevents the manufacturer from producing a directly competing product for another customer, but those clauses vary in scope and enforceability. If your agreement lacks one, or if it expired and rolled into an at-will arrangement, you have no contractual protection against i-Tail launching a similar product using the same equipment.

Second, assess how replaceable Phelps is for your specific product. Air-dried and jerky-style capacity is harder to replicate than extruded kibble, and switching co-manufacturers mid-contract often means reformulation, new production trials, and a gap in supply. If Phelps is your only source for a SKU that drives meaningful revenue, you are negotiating from a weaker position than if you have a backup producer already qualified.

Third, decide whether to renegotiate now or wait for the contract renewal. Bringing it up immediately signals that you see the conflict and expect terms that reflect it: a price concession, a longer exclusivity window, or a guarantee that your production schedule does not get bumped when i-Tail's own lines need capacity. Waiting until renewal means you are negotiating under whatever market conditions exist then, and i-Tail will have spent the interim learning your margins.

If your SKU list includes a contract-manufactured treat, subscribe to PetRetailNews.

The failure mode and what being wrong costs

The risk is not that i-Tail immediately launches a knockoff of your product. The risk is that over the next 12 to 24 months, i-Tail uses the visibility it now has into your formulation, your pricing, and your customer base to decide which categories to enter next, and it does so with better cost structure than you have because it owns the plant. A brand that stays with Phelps is weighing whether the operational continuity and the relationship with the production team outweigh the strategic disadvantage of handing a competitor that information. That calculation works if i-Tail's growth priorities stay in wet cat food and lickable treats rather than the jerky and air-dried categories Phelps is known for. It does not work if i-Tail decides that dog treats are the faster path to its $1.5 billion revenue target.

For the store owner, the consequence is different: if brands start pulling volume from Phelps and shifting to other co-manufacturers, expect supply disruptions on SKUs that were previously stable, and expect some of those SKUs to disappear entirely when a brand decides the switching cost is higher than the product's contribution margin. The consolidation also means fewer independent contract manufacturers in the treat category, which over time gives the remaining players more pricing power when supplier agreements renew.

What the deal signals about where treat capacity is going

In the first half of fiscal 2026, i-Tail's US revenue climbed 17.9% year over year, and the company added six new customers in that span. Second-quarter sales in the Americas rose 14% year over year, fueled by ongoing orders from global pet food companies and accelerating private label volume. The acquisition gives i-Tail owned production capacity in its biggest geographic market and widens its supply network across retail and distribution channels.

Phelps was founded in 1966 and serves retailers and pet food brands in the US, Canada, and other markets. The company's 25.6% compound annual growth rate between 2023 and 2025 reflects the broader category shift toward air-dried and jerky-style treats, which command higher price points than extruded products and appeal to pet owners seeking functional benefits and cleaner ingredient panels. According to i-Tail, treats was its fastest-growing segment in the second quarter of fiscal 2026, and the company anticipates further expansion in the category as pet owner preferences continue to shift.

Our read: the deal is about capacity, not innovation. i-Tail is buying production scale in a high-growth category and a physical footprint in the market that buys the most treats. The brands that contract with Phelps are now deciding whether that capacity is replaceable or whether the relationship and the production continuity are worth the trade-off of sharing a roof with a competitor.

Get the next issue in your inbox. Free, weekly, no fluff.

Unsubscribe anytime.

Source: Global Pet Industry ↗

← Back to the Newsdesk